Sterling Drug formed a joint venture in Japan.
- Share via
The New York-based pharmaceutical concern and Tokyo-based Yamanouchi Pharmaceutical Co. have agreed to establish a joint-venture company to market a line of prescription drugs in Japan, the world’s second-largest pharmaceuticals market after the United States. Sterling is a worldwide drug manufacturer and marketer with annual sales approaching $2 billion.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
